Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.
Published 4 years ago on Jun 5th 2021, 6:33 am
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters
5.2-magnitude earthquake jolts Indonesia’s East Java
- 12 گھنٹے قبل
How TikTok, micro-dramas, and distracted viewers are reshaping TV
- ایک دن قبل
PM Shehbaz orders abolition of Export Development Surcharge
- 13 گھنٹے قبل
Malaria vaccine price cut set to protect 7m more children by 2030
- 12 گھنٹے قبل
Three personnel martyred in suicide attack on FC headquarters in Peshawar
- 12 گھنٹے قبل
Xi holds call with Trump: Chinese state media
- 6 گھنٹے قبل
Ex-Wake Forest, NBA'er Rodney Rogers dies at 54
- ایک دن قبل
Bollywood magnet Dharmendra passes away at 89
- 12 گھنٹے قبل
Chairman JCSC Sahir Shamshad pays farewell call on PM Shehbaz
- 13 گھنٹے قبل
PM Shehbaz vows to strengthen Pak-Saudi ties across all domains
- 7 گھنٹے قبل
Pakistan thrash Zimbabwe by 69 runs in T20I Tri-Nation series
- ایک دن قبل
Videos show police search for Marshawn Kneeland before death
- ایک دن قبل
You May Like
Trending
